Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Mercy Medical Center Now Offers Cutting Edge Genius™ 3D Mammography™ Exams from Hologic


News provided by

Mercy Health Services

Aug 22, 2024, 17:30 ET

Share this article

Share toX

Share this article

Share toX

The Tyanna O'Brien Center for Women's Imaging at Mercy Medical Center in Baltimore, Maryland.
The Tyanna O'Brien Center for Women's Imaging at Mercy Medical Center in Baltimore, Maryland.

Mercy Medical Center in Baltimore, Maryland, now offering patients Genius™ 3D Mammography™ exams featuring 3DQuorum technology developed by Hologic, Inc.

BALTIMORE, Md., Aug. 22, 2024 /PRNewswire-PRWeb/ -- Mercy Medical Center is now offering patients Genius™ 3D Mammography™ exams featuring 3DQuorum technology developed by Hologic, Inc., said D eepa Masrani, M.D., Director, The Tyanna O'Brien Center for Women's Imaging at Mercy.

Utilizing advanced breast tomosynthesis (3-dimensional) technology, Genius exams are clinically proven to significantly increase the detection of breast cancers and to decrease the number of women asked to return for additional testing.

"The Genius AI Detection Technology is designed to identify potential cancers in breast tomosynthesis images with high accuracy, and with a false positive rate that is much lower than in earlier software." -- Deepa Masrani, M.D.

Post this

"In conventional mammography, smaller breast cancers may be missed and normal tissue may appear as abnormal; this is typically due to the problem of overlapping tissue, leading to unnecessary patient callbacks. A Genius exam includes a 3-dimensional method of imaging that can greatly reduce this overlap effect," Dr. Masrani said.

A 3D screening mammogram (tomosynthesis) is a low-dose X-ray examination of the breast tissue recommended for women on a routine basis, as part of overall preventative health plan. Tomosynthesis the most advanced mammographic technology currently available. Through a landmark gift and investment from a generous donor, Mercy Medical Center was an early adopter of 3D technology.

"And now, with the Genius 3D system, we take this technology a step further. The Genius AI Detection Technology is designed to identify potential cancers in breast tomosynthesis images with high accuracy, and with a false positive rate that is much lower than in earlier software. This equates to about one additional cancer detected for every 10 cancers identified by the radiologist," Dr. Masrani said.

During tomosynthesis, an X-ray arm sweeps over the breast, taking multiple images. These images are then converted via computer into a stack of thin layers, allowing the radiologist to review the breast tissue one layer at a time.

"The 3D technology utilizes the Genius AI-powered analytics to reconstruct high-resolution, 3D data to produce 6mm 'SmartSlices' – the SmartSlices are designed to expedite radiologist reading time by reducing the number of images to review with no loss in image quality, sensitivity or accuracy. A radiologist reading SmartSlices has the number of 3D images to review reduced by two-thirds. This frees up more time for the radiologist to spend with the patient, addressing their questions and concerns," Dr. Masrani explained.

The Genius 3D Mammography exam provides a superior option for women of all breast densities than 2D alone. Research has found that:

  • The Genius 3D Mammography exam finds 20-65% more invasive breast cancers than 2D alone, an average increase of 41%.
  • Only the Genius 3D Mammography exam is FDA-approved as superior for women with dense breasts compared to 2D alone.
  • The Genius 3D Mammography exam reduces callbacks by up to 40% compared to 2D alone. 

"Mercy Medical Center's team of radiologists, breast surgeons, and other breast cancer specialists are committed to helping women determine the best breast cancer treatment options for their specific needs, guiding them through the diagnosis, treatment and healing process. By adding the Genius exam to our arsenal in the fight against breast cancer, we offer patients a more accurate tool for breast cancer screening," said Neil B. Friedman, M.D., FACS, Director of The Hoffberger Breast Center at Mercy and Medical Director of The Weinberg Center for Women's Health and Medicine at Mercy.

For more information, or to schedule a Genius 3D Mammography™ exam with Mercy's Center for Women's Imaging, please call 410-332-9012 and visit The Center for Women's Imaging at Mercy.

EDITOR'S NOTE – ADDITIONAL BACKGROUND:

About Genius™ 3D Mammography™ Exams

The breast is a three-dimensional object composed of different structures located at different heights within the breast. These structures can overlap and cause confusion when viewed as a flat two-dimensional image. This confusion of overlapping of tissue is a leading reason why small breast cancers may be missed and normal tissue may appear abnormal, leading to unnecessary callbacks. Using breast tomosynthesis technology, the Hologic system creates a 3-dimensional image of the breast structure, which enables radiologists to more clearly see through overlapping tissue to detect cancers, often at an earlier stage.

Hologic has introduced a new type of tomosynthesis images, called 3DQuorum™, which provides 6-mm thick slices (known as SmartSlices) with 70-micron pixel resolution, utilizing artificial intelligence and machine learning.

The Hologic system is the first FDA-approved breast tomosynthesis system in the U.S. The Genius™ 3D Mammography™ (a.k.a. Genius™ exam) is acquired on the Hologic® 3D Mammography™ system and consists of a 2D and 3D™ image set, where the 2D image can be either an acquired 2D image or a 2D image generated from the 3D™ image set. The Genius™ exam is only available on the Hologic 3D Mammography™ system.

About Hologic, Inc.

Hologic, Inc. is a global medical technology innovator focused on improving the health and well-being of women, their families and communities through early detection and treatment. Its advancements include invention of the world's first commercial 3D mammography system to find breast cancer earlier; leadership in testing for cervical cancer, sexually transmitted infections and respiratory illnesses; minimally invasive surgical technologies for uterine fibroids and abnormal uterine bleeding; and advanced vessel sealing and dissection devices. The company also champions women through the Hologic Global Women's Health Index, which provides a science-backed data framework for improving women's well-being.

Media Contact

Dan Collins, Mercy Health Services, 4103329714, [email protected], www.mdmercy.com

SOURCE Mercy Health Services

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.